Effectiveness of Using (Vanish XT) in Prevention of Occlusal Caries: a RCT
Launched by KING ABDULAZIZ UNIVERSITY · Oct 6, 2020
Trial Information
Current as of August 02, 2025
Unknown status
Keywords
ClinConnect Summary
material and method: The sample will comprise of 84 bilateral pairs of newly erupted first permanent molars in children with age of 6-9 years.This sample will be randomly selected after patient's screening from pediatric dentistry clinics at King Abdul-Aziz University Dental Hospital, Jeddah, Saudi Arabia. Informed written consent will be obtained from the parents prior to sampling.
Healthy children with all four first permanent molar will be included in the study. Children must have at least one pair of contralateral newly erupted first permanent molars free from caries. Teeth with deep p...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy children having no history of any systemic condition.
- • Children must have all four first permanent molar.
- • Children must have at least one pair of contralateral newly erupted first permanent molars free from caries.
- • Teeth with deep pits and fissures (at high risk for caries).
- • These molars should be free of caries, restorations, sealants, fracture, hypoplasia, or cracks.
- • High caries risk children.
- Exclusion Criteria:
- • Children whom their parents refused to sign the consent form.
- • Children older than 9 years old.
- • Medically compromised children.
- • Children having discolored grooves, restored, caries, or hypoplastic first permanent molars.
- • Children having proximal caries in first permanent molars.
- • Children whose antagonist teeth were extracted or not erupted.
- • Children with a known acrylate allergy.
- • Uncooperative children.
About King Abdulaziz University
King Abdulaziz University (KAU) is a leading academic institution located in Jeddah, Saudi Arabia, renowned for its commitment to advancing medical research and innovation. As a prominent clinical trial sponsor, KAU leverages its extensive resources and expertise to facilitate groundbreaking studies aimed at improving healthcare outcomes. The university fosters collaboration among multidisciplinary teams of researchers, clinicians, and industry partners, ensuring adherence to rigorous ethical standards and regulatory requirements. KAU is dedicated to enhancing scientific knowledge and translating research findings into practical applications that benefit patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jeddah, , Saudi Arabia
Jeddah, , Saudi Arabia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials